Fresenius Se Co Stock Return On Equity

FSNUF Stock  USD 34.66  0.00  0.00%   
Fresenius SE Co fundamentals help investors to digest information that contributes to Fresenius' financial success or failures. It also enables traders to predict the movement of Fresenius Pink Sheet. The fundamental analysis module provides a way to measure Fresenius' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Fresenius SE Co Company Return On Equity Analysis

Fresenius' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Fresenius Return On Equity

    
  0.0793  
Most of Fresenius' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius SE Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Fresenius SE Co has a Return On Equity of 0.0793. This is 100.33% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The return on equity for all United States stocks is 125.58% lower than that of the firm.

Fresenius Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresenius could also be used in its relative valuation, which is a method of valuing Fresenius by comparing valuation metrics of similar companies.
Fresenius is currently under evaluation in return on equity category among its peers.

Fresenius Fundamentals

About Fresenius Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Fresenius SE Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius SE Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Fresenius Pink Sheet

Fresenius financial ratios help investors to determine whether Fresenius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fresenius with respect to the benefits of owning Fresenius security.